rs35406175
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS2_Supporting
The NM_000519.4(HBD):c.14C>T(p.Thr5Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0016 in 1,612,808 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T5S) has been classified as Likely benign.
Frequency
Consequence
NM_000519.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HBD | NM_000519.4 | c.14C>T | p.Thr5Ile | missense_variant | 1/3 | ENST00000650601.1 | NP_000510.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBD | ENST00000650601.1 | c.14C>T | p.Thr5Ile | missense_variant | 1/3 | NM_000519.4 | ENSP00000497529 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00139 AC: 211AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00143 AC: 360AN: 251150Hom.: 1 AF XY: 0.00155 AC XY: 211AN XY: 135726
GnomAD4 exome AF: 0.00163 AC: 2377AN: 1460478Hom.: 4 Cov.: 30 AF XY: 0.00164 AC XY: 1191AN XY: 726686
GnomAD4 genome AF: 0.00139 AC: 211AN: 152330Hom.: 0 Cov.: 32 AF XY: 0.00130 AC XY: 97AN XY: 74494
ClinVar
Submissions by phenotype
delta Thalassemia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Oct 23, 2017 | The HBD c.14C>T (p.Thr5Ile) missense variant is reported across the literature in 31 individuals with varying thalassemia phenotypes, including in three compound heterozygotes, 18 heterozygotes, six cases where zygosity was not reported, and four individuals who carried multiple HBD variants in cis (Trifillis et al. 1993; De Angioletti et al. 2002; Lacerra et al. 2008; Phylipsen et al. 2011; Liu et al. 2013; Joly et al. 2013; Khalil et al. 2014; Hassan et al. 2014; Villegas et al. 2016). In the majority of these cases, the individuals carried variants in other thalassemia-associated genes so it is unclear which variant may be causative. The p.Thr5Ile variant is reported at a frequency of 0.014019 in the Iberian populations in Spain from the 1000 Genomes Project. Additionally, one homozygote is reported in the European (non-Finnish) population of the Exome Aggregation Consortium and the Genome Aggregation Database. The p.Thr5Ile variant is classified as a variant of unknown significance but suspicious for pathogenicity for delta thalassemia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at